Study results suggest that surgical aortic valve replacement (SAVR) and transfemoral transcatheter aortic valve replacement (TAVR) appears to have comparable short-term outcomes. The all-cause mortality rate at 1 year was 13.8% for transfemoral TAVR and 13.6% for SAVR. Rates of death from any cause and major adverse cardiac and cerebrovascular events were 18.2% for transfemoral TAVR and 17.6% for SAVR. The incidence rates for cerebrovascular events and rehospitalization due to cardiac reasons and acute heart failure were also similar for both groups at 1 year.
Black Patients Have Higher Burden of Comorbidities but Lower Risk of 30-Day and One-Year Mortality After Thoracic Endovascular Aortic Repair.
December 7, 2020
Pulmonary Vascular Pressures and Gas Exchange Response to Exercise in Heart Failure with Preserved Ejection Fraction.
August 6, 2020
May 2, 2013
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.